IP Library Granted Patent US 10,499,848
Granted Patent B2
US 10,499,848 · App. 15/918,779 · Granted Dec 10, 2019

System for analyzing and treating abnormality of human and animal tissues

Inventor: Ronald J. Weinstock (Corona Del Mar, CA)
Assignee: TrueRelief, LLC
A61B5/4836A61B5/0035A61B5/055A61B5/742A61N1/36021A61N2/002A61N2/008A61N2/02A61N5/10G01R33/60A61B5/053A61N2005/1087A61N2005/1091
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,499,848
App. No.
15/918,779
Granted
Dec 10, 2019
Kind
B2
Abstract

A patient treatment unit for analyzing and treating abnormality of human or animal tissues, includes a display; a pulse generator circuit that outputs a sequence of electrical pulses at a pulse frequency, the electrical pulses having a pulse width, the pulse generator controlling the pulse frequency and the pulse width of the electrical pulses; a pair of probes for contacting a body of a patient and electrically coupled to the pulse generator; and a voltage and current sensing circuit that senses a voltage or a current via the probes when contacting the body of the patient.

Claims (18)

1. A patient treatment unit for treating abnormality of human or animal tissues, comprising:

a display;

a first electrical circuit that outputs a sequence of direct current electrical pulses at a pulse frequency, the direct current electrical pulses having a pulse width, the first electrical circuit controlling the pulse frequency and the pulse width of the direct current electrical pulses, where the pulse frequency is in a range of 5 Hz to 30 kHz;

a first conductor and a second conductor for contacting a body of a patient and electrically coupled to the first electrical circuit such that the direct current electrical pulses are delivered through the conductors in response to both of the first and the second conductors being in direct physical contact with the body of the patient, each of the first and the second conductors being coupled to the first electrical circuit by a respective wire; and

a control input configured to adjust or select an intensity of the energy applied between the conductors to the body.

2. The patient treatment unit of claim 1 , a voltage and current sensing circuit that senses a voltage or a current via the probes when contacting the body of the patient.

3. The patient treatment unit of claim 1 , further comprising a circuit configured to detect an overvoltage or an overcurrent in the electrical pulses.

4. The patient treatment unit of claim 1 , wherein the direct current electrical pulses are substantially rectangular pulses when the first and second conductors have a substantially open circuit between them.

5. The patient treatment unit of claim 1 , wherein the pulse width is not less than 0.34 milliseconds and is not greater than 0.74 milliseconds.

6. The patient treatment unit of claim 1 , wherein at least one of the first or the second conductors is part of a skin-electrode.

7. The patient treatment unit of claim 6 , wherein the other of the first or the second conductors is in the form of a probe.

8. The patient treatment unit of claim 1 , further comprising a battery pack.

9. The patient treatment unit of claim 1 , wherein the control input includes or is coupled to a potentiometer that is configured to adjust a characteristic of the direct current electrical pulses relating to the intensity of the energy.

10. The patient treatment unit of claim 1 , wherein the maximum current output of the pulse generator circuit is not greater than 8.9 milliamps.

11. The patient treatment unit of claim 1 , wherein a peak amplitude of the electrical pulses is 120 V.

12. The patient treatment unit of claim 1 , further comprising a microcontroller for controlling the display.

13. A method of reducing pain associated with arthritis, fibromyalgia, neuralgia, neuropathy, joint injury, tissue injury, a wound, calcific tendonitis, or a migraine headache, using the patient treatment unit of claim 1 .

14. The patient treatment unit of claim 1 , wherein reduction of pain in the body is achieved by excitation of nociceptive neurons through delivery of the energy through the conductors coupled with mechanical stimuli supplied by the first or the second conductors.

Assignments (4)
SECURITY INTEREST Recorded Jun 5, 2026
From: TRUERELIEF, LLC
To: GLS HOLDINGS, LLC
Reel/Frame 074862/0970 →
SECURITY INTEREST Recorded Apr 21, 2026
From: TRUERELIEF, LLC
To: MEDCAP PARTNERS, LLC
Reel/Frame 074431/0795 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 7, 2018
From: NEWLIFE SCIENCES LLC
To: TRUERELIEF, LLC
Reel/Frame 047711/0280 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 13, 2018
From: WEINSTOCK, RONALD J.
To: NEWLIFE SCIENCES, LLC
Reel/Frame 045189/0418 →
Continuity (9)
Continuation 15378357 · Dec 14, 2016
Continuation 14736827 · Jun 11, 2015
Continuation 14338700 · Jul 23, 2014
Continuation 13690752 · Nov 30, 2012
Continuation 13269017 · Oct 7, 2011
Continuation 12456657 · Jun 19, 2009
Continuation 10856632 · May 28, 2004
Provisional Application 60478843 · Jun 2, 2003
Related Publication 20180263554A1 · Sep 20, 2018
Cited By (5)
US 12,390,639 US 12,453,853 US 12,533,506 US 12,575,780 US 12,629,522